Liftstream announces attendance of World Orphan Drug Congress
26 February 2014
On 26th February 2014 Liftstream Ltd, the Life Sciences Executive Search and Interim Management company, announced its attendance of the World Orphan Drug Congress 2014 in Washington, USA on April 23rd – 25th inclusive. Liftstream will attend this key orphan drugs and rare diseases industry congress, one of the largest global industry events for rare diseases.
Liftstream Founder & CEO, Karl Simpson, said “Liftstream has been very active in the orphan drugs and rare disease space since our inception in 2003. The World Orphan Drug congress offers a fantastic opportunity to engage with leaders in this field. The rare disease and orphan drug space is one of the hottest areas in the industry at the moment and this conference allows us to be remain at the heart of the sector”
He added, “2013 was a very exciting year for developments in the orphan drug business with considerable therapeutic advances, licensing transactions and heightened investment of private and public capital. 2014 therefore, should be a great event to see how the industry is reacting to these dynamic changes.”
The World Orphan Drug Congress 2014 will bring together some of the most notable innovators in the market who are contributing to the progression of therapies and diagnostics which address rare diseases.
Liftstream Limited, headquartered in London UK, is an executive search recruitment and interim management staffing company operating exclusively within the life sciences sector. Liftstream provides experienced professional, executive management and Board executives to companies in the sectors of Pharmaceuticals, Biotechnology, Medical Diagnostics and Medical Diagnostics. Liftstream utilising market research and intelligence as well as high level community engagement to deliver effective recruitment projects for client partners. For additional information, visit https://www.liftstream.com or follow Liftstream on Twitter (@Liftstream).
Back to news and press releases